30175132|t|Mutation Study of Malaysian Patients with Ornithine Transcarbamylase Deficiency: Clinical, Molecular, and Bioinformatics Analyses of Two Novel Missense Mutations of the OTC Gene.
30175132|a|Ornithine transcarbamylase deficiency (OTCD), an X-linked disorder that results from mutations in the OTC gene, causes hyperammonemia and leads to various clinical manifestations. Mutations occurring close to the catalytic site of OTCase can cause severe OTCD phenotypes compared with those caused by mutations occurring on the surface of this protein. In this study, we report two novel OTC missense mutations, Q171H and N199H, found in Malaysian patients. Q171H and N199H caused neonatal onset OTCD in a male and late OTCD in a female, respectively. In silico predictions and molecular docking were performed to examine the effect of these novel mutations, and the results were compared with other 30 known OTC mutations. In silico servers predicted that Q171H and N199H, as well as 30 known missense mutations, led to the development of OTCD. Docking analysis indicated that N-(phosphonoacetyl)-L-ornithine (PALO) was bound to the catalytic site of OTCase mutant structure with minimal conformational changes. However, the mutations disrupted interatomic interactions in the catalytic site. Therefore, depending on the severity of disruption occurring at the catalytic site, the mutation may affect the efficiency of mechanism and functions of OTCase.
30175132	28	36	Patients	Species	9606
30175132	42	79	Ornithine Transcarbamylase Deficiency	Disease	MESH:D020163
30175132	169	172	OTC	Gene	5009
30175132	179	216	Ornithine transcarbamylase deficiency	Disease	MESH:D020163
30175132	218	222	OTCD	Disease	MESH:D020163
30175132	228	245	X-linked disorder	Disease	MESH:D040181
30175132	281	284	OTC	Gene	5009
30175132	298	312	hyperammonemia	Disease	MESH:D022124
30175132	410	416	OTCase	Gene	5009
30175132	434	438	OTCD	Disease	MESH:D020163
30175132	567	570	OTC	Gene	5009
30175132	591	596	Q171H	ProteinMutation	tmVar:p|SUB|Q|171|H;HGVS:p.Q171H;VariantGroup:1;CorrespondingGene:5009;CorrespondingSpecies:9606
30175132	601	606	N199H	ProteinMutation	tmVar:p|SUB|N|199|H;HGVS:p.N199H;VariantGroup:0;CorrespondingGene:5009;CorrespondingSpecies:9606
30175132	627	635	patients	Species	9606
30175132	637	642	Q171H	ProteinMutation	tmVar:p|SUB|Q|171|H;HGVS:p.Q171H;VariantGroup:1;CorrespondingGene:5009;CorrespondingSpecies:9606
30175132	647	652	N199H	ProteinMutation	tmVar:p|SUB|N|199|H;HGVS:p.N199H;VariantGroup:0;CorrespondingGene:5009;CorrespondingSpecies:9606
30175132	675	679	OTCD	Disease	MESH:D020163
30175132	699	703	OTCD	Disease	MESH:D020163
30175132	888	891	OTC	Gene	5009
30175132	936	941	Q171H	ProteinMutation	tmVar:p|SUB|Q|171|H;HGVS:p.Q171H;VariantGroup:1;CorrespondingGene:5009;CorrespondingSpecies:9606
30175132	946	951	N199H	ProteinMutation	tmVar:p|SUB|N|199|H;HGVS:p.N199H;VariantGroup:0;CorrespondingGene:5009;CorrespondingSpecies:9606
30175132	1019	1023	OTCD	Disease	MESH:D020163
30175132	1057	1088	N-(phosphonoacetyl)-L-ornithine	Chemical	MESH:C020464
30175132	1090	1094	PALO	Chemical	MESH:C020464
30175132	1131	1137	OTCase	Gene	5009
30175132	1426	1432	OTCase	Gene	5009
30175132	Positive_Correlation	MESH:D020163	HGVS:p.Q171H;CorrespondingGene:5009
30175132	Association	MESH:C020464	5009
30175132	Positive_Correlation	MESH:D020163	HGVS:p.N199H;CorrespondingGene:5009
30175132	Association	MESH:D020163	5009
30175132	Association	MESH:D020163	5009

